Article
Author(s):
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 23, 2022.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
The American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting offers opportunities for physicians, technologists, and other healthcare professionals to learn about the latest in neuromuscular, musculoskeletal, and electrodiagnostic medicine. Check in on all of NeurologyLive®'s coverage, coming right from the conference floor.
Mind Moments®, a podcast from NeurologyLive® features an exclusive interview with Ambereen Mehta, MD, MPH, who detailed the history of palliative care in the United States and offered insight into the potential of adopting a palliative care model across neurologic disease care.
In the latest edition of our in-depth Q&A series, the director of NYU Langone’s Alzheimer’s Disease Research Center and Center for Cognitive Neurology provided perspective on raising awareness for World Alzheimer’s Day and the ongoing challenges patients with the disease face.
In episode 10 of this NeurologyLive® Peer Exchange series, "Multiple Sclerosis Treatments on the Horizon: BTK Inhibitors," Ahmed Obeidat, MD, PhD; Benjamin Greenberg, MD; and Hesham Abboud, MD, PhD, share their experiences with patient compliance and the route of administration of current and emerging therapies for multiple sclerosis.
The pulmonologist at Penn Medicine provided an evaluation on whether patients with insomnia receive optimal care, and which treatments have proven to be most effective.